dc.contributor.author | Ersoy, Suleyman | |
dc.contributor.author | Benli, Ali Ramazan | |
dc.contributor.author | Engin, Velittin Selçuk | |
dc.contributor.author | Pala, Emin | |
dc.date.accessioned | 2022-07-04T16:48:16Z | |
dc.date.available | 2022-07-04T16:48:16Z | |
dc.identifier.citation | Pala E., Ersoy S., Engin V. S. , Benli A. R. , "Effectiveness of STOPP/START criteria in primary prevention of polypharmacy and under-treatment in older patients", Therapies, 2021 | |
dc.identifier.issn | 0040-5957 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_fa58d496-24de-462f-810d-62c12aab3026 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/185456 | |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85120646832&origin=inward | |
dc.identifier.uri | https://doi.org/10.1016/j.therap.2021.07.003 | |
dc.description.abstract | © 2021 Société française de pharmacologie et de thérapeutiqueAim of the study: STOPP/START criteria appear to be a useful tool to curb inappropriate prescribing (IP), which encompasses errors of both, over and under-treatment. This study aimed to find out whether application of STOPP/START reduces the IP effectively in primary care. Methods: This prospective cross-sectional study was conducted in two family health centers (FHCs) in Istanbul. All older adults who applied to FHCs between 01-07-2018 and 01-07-2020 were enrolled. The potential inappropriate medications (PIMs) and potential prescription omissions (PPOs) were identified according to STOPP/START version 2 criteria. Mean drug consumptions before and after STOPP/START were compared using Student's t-test. Results: Among 1023 participants there were 626 females and 397 males. The mean age was 73.33 ± 7.30 years. The number of the patients seen at FHCs was 657 (64.2%) while 366 (35.8%) of them were visited at home. Of the patients, 383 (37.8) were 75 years old or older and 631 (62.2%) of them were under 75. Overall number of drugs consumed per patient was 5.49 ± 3.93 while it was 6.01 ± 3.71 and 4.55 ± 4.138 for outpatients and home patients respectively (p < 0.001). By application of STOPP criteria, among the 5616 medications consumed by the overall patients, 881(%15.6) of them were found to be potentially inappropriate. 424 (41.4%) patients were using at least one PIM. This ratio was 354 (53.8%) in outpatients and 70 (19%) in home patients. START criteria identified 380 (%7.4) PPOs. There were 246 (24.0%) patients with at least with one PPO; 155 (42.3%) of whom were home patients and 91 (13.8%) were outpatients. Regarding the age groups; PIM ratio was 35.5% in patients under 75 and 52.1% over 75 whereas PPO ratio was 22.5% under 75 and 26.8% over 75. Conclusion: This study supports the data reporting the effectiveness of STOPP/START criteria in primary care units in implementing appropriate prescription criteria. | |
dc.language.iso | eng | |
dc.subject | Pharmacology (medical) | |
dc.subject | Health Sciences | |
dc.subject | Yaşam Bilimleri | |
dc.subject | Temel Bilimler | |
dc.subject | Eczacılık | |
dc.subject | Sağlık Bilimleri | |
dc.subject | FARMAKOLOJİ VE ECZACILIK | |
dc.subject | Farmakoloji ve Toksikoloji | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.subject | Temel Eczacılık Bilimleri | |
dc.title | Effectiveness of STOPP/START criteria in primary prevention of polypharmacy and under-treatment in older patients | |
dc.type | Makale | |
dc.relation.journal | Therapies | |
dc.contributor.department | University of Health Sciences , , | |
dc.contributor.firstauthorID | 3403867 | |